Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-09-03 07:30 |
THERANEXUS ANNONCE LA PUBLICATION DE DEUX ARTICLES SCIENTIFIQUES ET UNE PRÉSENT…
|
French | 310.3 KB | ||
| 2019-07-11 09:30 |
THERANEXUS RAISES APPROXIMATELY 2.2 MILLION EUROS IN A PLACEMENT RESERVED TO A …
|
English | 497.0 KB | ||
| 2019-07-11 09:05 |
THERANEXUS LEVE 2,2 MILLIONS D'EUROS DANS LE CADRE D'UN PLACEMENT RESERVE A UNE…
|
French | 305.3 KB | ||
| 2019-07-10 18:50 |
THERANEXUS ANNOUNCES THE LAUNCH OF A CAPITAL INCREASE BY PRIVATE PLACEMENT FOR …
|
English | 291.5 KB | ||
| 2019-07-10 18:45 |
Erratum- THERANEXUS ANNONCE LE LANCEMENT D'UNE AUGMENTATION DE CAPITAL PAR PLAC…
|
French | 297.8 KB | ||
| 2019-07-10 18:05 |
THERANEXUS ANNONCE LE LANCEMENT D'UNE AUGMENTATION DE CAPITAL PAR PLACEMENT RÉS…
|
French | 302.7 KB | ||
| 2019-07-08 18:50 |
THERANEXUS REPORTS CASH POSITION AS OF JUNE 30, 2019
|
English | 267.7 KB | ||
| 2019-07-08 18:35 |
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 JUIN 2019
|
French | 283.9 KB | ||
| 2019-06-27 18:00 |
Theranexus and Beyond Batten Disease Foundation (BBDF) announce agreement in pr…
|
English | 347.8 KB | ||
| 2019-06-27 18:00 |
Theranexus et ' Beyond Batten Disease Foundation ' (BBDF) annoncent un accord d…
|
French | 313.8 KB | ||
| 2019-06-20 07:30 |
THERANEXUS PARTICIPERA AU HEALTHTECH INVESTOR DAYS (HTID) LES 24 ET 25 JUIN À P…
|
French | 276.0 KB | ||
| 2019-06-20 07:30 |
THERANEXUS INVITED TO JOIN IN THE HEALTHTECH INVESTOR DAYS (HTID) 24 and 25 JUN…
|
English | 363.0 KB | ||
| 2019-06-04 18:00 |
THERANEXUS ANNOUNCES THE FORMATION OF ITS SCIENTIFIC BOARD
|
English | 374.5 KB | ||
| 2019-06-04 18:00 |
THERANEXUS ANNONCE LA CONSTITUTION DE SON CONSEIL SCIENTIFIQUE
|
French | 288.1 KB | ||
| 2019-05-23 08:00 |
THERANEXUS TO PRESENT NEW DATA ON NEURON-GLIA INTERACTIONS AT TWO SCIENTIFIC EV…
|
English | 379.3 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
